The NDDC launches a sickle cell awareness campaign in Delta, providing medical support, drugs, and education to patients and ...

Developed by UCL spinout Autolus, Aucatzyl will be launched imminently across England and Wales. A UK-developed cell therapy ...

Lawmakers raise concerns over FDA drug voucher program citing safety risks, transparency issues, and legal questions in a Nov. 20 letter to agency leaders.

Cardiologist and Men's Health advisory board member Christopher Kelly, MD, says this treatment is "approaching magic" for ...

Q3 2025 Earnings Call Transcript November 24, 2025 BioLineRx Ltd. beats earnings expectations. Reported EPS is $-0.22, ...

Pies does not see anything fundamentally broken in today’s markets and stated that if we go through our checklist, we can see ...

YourStory presents the daily news roundup from the Indian startup ecosystem and beyond. Here's the roundup for Tuesday, November 25, 2025 ...

BLRX READ THE FULL BLRX RESEARCH REPORT BioLineRx Ltd. (NASDAQ:BLRX) reported third quarter 2025 results, producing license revenues of $427,000. Following the September announcement of the joint ...

A next-generation treatment from Novo Nordisk helped patients with diabetes lower their blood sugar and lose weight in a ...

The U.S. Food and Drug Administration has approved Novartis' gene therapy for patients with a rare muscle disorder, the drugmaker said on Monday.

Biomedical research that began at the University of Virginia School of Medicine has yielded a much-needed new treatment for ...